Aguiar-Ibáñez R, Mbous Ypv, Sharma Sugandh, Chakali R, Chawla E
Merck Canada Inc., Kirkland, QC, Canada.
Merck & Co., Inc., Rahway, NJ, United States.
Front Oncol. 2025 Aug 6;15:1575820. doi: 10.3389/fonc.2025.1575820. eCollection 2025.
Cancer screening programs play a crucial role in early detection, improving survival rates and reducing the burden of advanced cancer. However, uptake remains inconsistent due to multifaceted barriers. This systematic review aimed to identify factors that impact cancer screening uptake across multiple tumor types and interventions to overcome barriers to cancer screening uptake.
A systematic literature review (SLR) was conducted using Embase and MEDLINE (May 2012 to May 2022) to identify observational studies that reported factors associated with screening uptake in adults, worldwide, with no tumor-specific restrictions. Records identified were screened by two independent reviewers. Included studies were data extracted by two reviewers and the results were reported narratively, focusing on identifying factors that acted as barriers or facilitators to cancer screening uptake, along with potential interventions to improve screening uptake.
Overall, 811 studies were identified from the SLR that reported factors influencing the uptake of screening programs, with 658 studies covering screening programs for breast, cervical, lung, colorectal, gastric and prostate cancers. Barriers to cancer screening included: being unmarried, experiencing higher deprivation, lower socioeconomic status and rural living conditions. Facilitators to cancer screening included: older age, poor perception of health, previous cancer history, family history of cancer, previous cancer screening history, having knowledge of the disease, positive attitudes to screening, perceived cancer risk, higher education level, having children, higher income, higher socioeconomic status, having health insurance, urban residence, having access to care, and recommendations for screening by primary care physicians. Mixed findings were identified for race and ethnicity, employment and smoking status. Targeted educational programs were the most suggested strategy to overcome barriers to cancer screening uptake.
Barriers to cancer screening across multiple tumor types are complex, spanning demographic and patient-level factors, social and economic factors, provider and community challenges, and access to health care. While certain barriers are shared across tumor types, others are unique, reflecting the specific requirements of screening for different tumors. Addressing these barriers requires multi-level strategies that integrate both universal and cancer-specific approaches. Targeted interventions and supportive policies can increase screening participation, facilitate earlier cancer diagnosis, and reduce disparities in cancer outcomes.
癌症筛查项目在早期检测、提高生存率和减轻晚期癌症负担方面发挥着关键作用。然而,由于多方面的障碍,其接受程度仍然参差不齐。本系统评价旨在确定影响多种肿瘤类型癌症筛查接受程度的因素以及克服癌症筛查接受障碍的干预措施。
使用Embase和MEDLINE(2012年5月至2022年5月)进行系统文献综述(SLR),以识别在全球范围内报道与成人筛查接受程度相关因素的观察性研究,且无肿瘤特异性限制。两名独立评审员对识别出的记录进行筛选。纳入研究由两名评审员提取数据,并以叙述方式报告结果,重点是确定作为癌症筛查接受障碍或促进因素的因素,以及改善筛查接受程度的潜在干预措施。
总体而言,从SLR中识别出811项报告影响筛查项目接受程度因素的研究,其中658项研究涵盖乳腺癌、宫颈癌、肺癌、结直肠癌、胃癌和前列腺癌的筛查项目。癌症筛查的障碍包括:未婚、贫困程度较高、社会经济地位较低和农村生活条件。癌症筛查的促进因素包括:年龄较大、对健康感知较差、既往癌症史、癌症家族史、既往癌症筛查史、了解疾病、对筛查持积极态度、感知癌症风险、教育水平较高、育有子女、收入较高、社会经济地位较高、拥有医疗保险、城市居住、能够获得医疗服务以及初级保健医生的筛查建议。在种族和民族、就业和吸烟状况方面发现了混合结果。针对性教育项目是克服癌症筛查接受障碍最常被建议的策略。
多种肿瘤类型的癌症筛查障碍是复杂的,涵盖人口统计学和患者层面因素、社会和经济因素、提供者和社区挑战以及获得医疗保健的机会。虽然某些障碍在不同肿瘤类型中是共有的,但其他障碍是独特的,反映了不同肿瘤筛查的特定要求。解决这些障碍需要整合通用方法和癌症特异性方法的多层次策略。针对性干预措施和支持性政策可以增加筛查参与度,促进癌症早期诊断,并减少癌症结局的差异。